Inflammatory bowel diseases [IBD] such as Crohn's disease [CD] and ulcerative colitis [UC]
are complex conditions presenting with a wide range of phenotypes. Given major variation …

Inflammatory bowel diseases [IBD] are a heterogeneous spectrum with two extreme
phenotypes, Crohn's disease [CD] and ulcerative colitis [UC], which both represent …

Despite advances in our understanding of the pathophysiology underlying inflammatory
bowel disease, there remains a significant need for biomarkers that can differentiate …

ABSTRACT Introduction: Inflammatory bowel diseases (IBDs) are lifelong conditions
causing relapsing inflammation of the intestine. In the absence of a cure, clinical …

Background The course of Crohn's disease (CD) varies substantially between individuals,
but reliable prognostic markers do not exist. This hinders disease management because …

Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn's disease
(CD), is a costly condition in terms of morbidity and healthcare utilization, with an increasing …

Unambiguous diagnosis of the two main forms of inflammatory bowel diseases (IBD):
Ulcerative colitis (UC) and Crohn's disease (CD), represents a challenge in the early stages …

Crohn's disease and ulcerative colitis, the two most common inflammatory bowel diseases
(IBD), are characterized by chronic relapsing inflammation. Although recent progress …

Introduction Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's
disease, can be challenging to diagnose, and treatment outcomes are difficult to predict. In …

There is no gold standard for the diagnosis and monitoring of inflammatory bowel diseases
(IBD). Biomarkers are useful tools for the management of patients suffering from IBD …